ASTEC.NS
Astec LifeSciences Limited
NSEINREQUITY
Basic Materials
DELAYED
Last price
601.00
▼ 0.80 (0.13%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
601.25
Prev close
601.80
Day high
619.40
Day low
601.00
Volume
22.07K
Market cap
$13.39B
P/E (TTM)
—
52W range
513.40 – 941.75
Day trading desk
Gap from prior close
-0.09%
Prior close 601.80
VWAP
604.58
-0.59% from price
Relative volume
0.67×
Normal
Session range
3.06%
601.00 – 619.40
Position in range
0%
Near session low
ATR (14D)
24.17
4.02% of price
Prior day high
624.00
PDH
Prior day low
598.00
PDL
Bid / ask spread
—
Quote not published
Session volume
43.76K
Avg 64.89K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.33%
+2.7%
1M
-9.57%
-13.3%
3M
-19.43%
-22.5%
6M
-5.87%
-16.9%
YTD
-14.63%
-26.9%
1Y
-27.33%
-47.3%
3Y
-51.39%
-125.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ASTEC.NS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
16.28M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 29, 25 | Godrej Agrovet Pvt. Promoter |
OTHER | 2.24M | $22.85M | Direct |
| Jan 1, 25 | Dubash (Tanya) Promoter |
BUY | 134.95K | $1.73M | Direct |
| Jan 1, 25 | Godrej (Nadir) Promoter |
BUY | 404.78K | $5.18M | Direct |
| Jan 1, 25 | Godrej (Nisaba) Promoter |
BUY | 134.95K | $1.73M | Direct |
| Jan 1, 25 | Godrej (Pirojsha) Promoter |
BUY | 134.87K | $1.72M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Dubash (Tanya) |
Promoter | 134.95K | Acquisition |
Godrej (Nadir) |
Promoter | 404.78K | Acquisition |
Godrej (Nisaba) |
Promoter | 134.95K | Acquisition |
Godrej (Pirojsha) |
Promoter | 134.87K | Acquisition |
Godrej Agrovet Pvt. |
Promoter | 14.94M | Other |
Fundamentals
Market cap$13.39B
Enterprise value$17.80B
Revenue (TTM)$4.41B
Gross profit$1.54B
EBITDA$57.63M
Net income$-665.97M
EPS (TTM)$-29.31
Free cash flow—
Total cash$100.49M
Total debt$4.49B
Book value / share$175.30
Shares outstanding22.28M
Float5.51M
Short % of float—
Dividend yield—
Beta (5Y)0.20
Valuation & profitability ratios
Trailing P/E—
Forward P/E54.64
PEG ratio—
Price / sales—
Price / book3.43
EV / revenue4.04
EV / EBITDA308.92
Gross margin34.86%
Operating margin-14.04%
Profit margin-15.11%
Return on equity—
Return on assets—
Debt / equity114.84
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.46B | $3.78B | $4.58B | $6.28B | +17.9% |
| Operating revenue | $4.46B | $3.78B | $4.58B | $6.28B | +17.9% |
| Cost of revenue | $3.04B | $3.03B | $3.23B | $4.05B | +0.3% |
| Gross profit | $1.42B | $754.34M | $1.34B | $2.23B | +88.3% |
| Research & development | $24.62M | $21.36M | $27.00M | $14.85M | +15.3% |
| Selling, general & admin | $118.69M | $123.73M | $97.64M | $197.67M | -4.1% |
| Total operating expense | $1.91B | $1.85B | $1.76B | $1.79B | +3.6% |
| Operating income | -$493.82M | -$1.09B | -$415.94M | $435.27M | +54.8% |
| Net interest income | -$340.08M | -$358.94M | -$250.75M | -$166.65M | +5.3% |
| Pre-tax income | -$810.00M | -$1.41B | -$617.48M | $349.47M | +42.5% |
| Tax provision | -$1.24M | -$62.77M | -$148.57M | $93.53M | +98.0% |
| Net income | -$809.17M | -$1.35B | -$469.30M | $255.65M | +40.0% |
| Net income to common | -$809.17M | -$1.35B | -$469.30M | $255.65M | +40.0% |
| Basic EPS | -37.79 | -68.71 | -23.75 | 12.94 | +45.0% |
| Diluted EPS | -37.79 | -68.71 | -23.75 | 12.94 | +45.0% |
| EBIT | -$469.20M | -$1.05B | -$368.92M | $551.06M | +55.2% |
| EBITDA | -$19.99M | -$609.99M | -$6.38M | $887.58M | +96.7% |
| Basic shares | 21.41M | 19.61M | 19.76M | 19.75M | +9.2% |
| Diluted shares | 21.41M | 19.61M | 19.76M | 19.76M | +9.2% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $100.49M | $5.75M | $4.71M | $4.73M | +1,646.4% |
| Cash & short-term investments | $105.36M | $8.55M | $16.47M | $7.20M | +1,132.3% |
| Accounts receivable | $2.48B | $1.47B | $1.69B | $1.55B | +68.0% |
| Inventory | $1.38B | $1.60B | $1.96B | $2.95B | -13.6% |
| Total current assets | $4.43B | $3.41B | $3.98B | $4.99B | +29.9% |
| Property, plant & equipment | $4.55B | $4.98B | $5.32B | $4.41B | -8.6% |
| Goodwill & intangibles | $247.55M | $234.49M | $194.16M | $159.04M | +5.6% |
| Total assets | $9.42B | $8.81B | $9.75B | $9.79B | +6.9% |
| Total current liabilities | $5.00B | $3.66B | $3.97B | $5.26B | +36.7% |
| Current debt | $3.99B | $2.75B | $2.95B | $3.30B | +45.3% |
| Long-term debt | $500.00M | $2.80B | $1.99B | $108.63M | -82.1% |
| Total debt | $4.49B | $5.55B | $4.94B | $3.41B | -19.0% |
| Total liabilities | $5.51B | $6.46B | $6.05B | $5.60B | -14.7% |
| Retained earnings | $606.90M | $1.41B | $2.76B | $3.26B | -57.0% |
| Shareholder equity | $3.91B | $2.35B | $3.69B | $4.19B | +66.4% |
| Working capital | -$567.95M | -$245.75M | $13.33M | -$273.47M | -131.1% |
| Net tangible assets | $3.66B | $2.11B | $3.50B | $4.03B | +73.1% |
| Shares issued | 22.28M | 19.76M | 19.76M | 19.76M | +12.8% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$810.00M | -$1.41B | -$617.48M | $349.47M | — | +42.5% |
| Depreciation & amortisation | $449.22M | $437.14M | $362.53M | $336.52M | — | +2.8% |
| Stock-based compensation | $925.00K | $345.00K | $3.01M | $3.31M | — | +168.1% |
| Change in working capital | -$778.96M | $265.27M | $104.94M | -$59.06M | — | -393.6% |
| Operating cash flow | -$807.08M | -$83.99M | $102.21M | $746.56M | — | -861.0% |
| Capital expenditure | -$55.36M | -$218.22M | -$1.35B | -$1.17B | — | +74.6% |
| Investing cash flow | -$43.06M | -$152.30M | -$1.35B | -$1.13B | — | +71.7% |
| Dividends paid | — | — | -$29.41M | -$29.41M | -$29.38M | — |
| Financing cash flow | $944.87M | $237.33M | $1.25B | $377.70M | — | +298.1% |
| Free cash flow | -$862.43M | -$302.20M | -$1.25B | -$426.03M | — | -185.4% |
| End cash position | $100.49M | $5.75M | $4.71M | $4.73M | — | +1,646.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $835.64M | $1.59B | $1.25B | $910.82M | $1.20B | -47.3% |
| Operating revenue | $835.64M | $1.59B | $1.25B | $910.82M | $1.20B | -47.3% |
| Cost of revenue | $426.19M | $1.10B | $829.12M | $638.84M | $735.37M | -61.4% |
| Gross profit | $409.45M | $482.86M | $418.08M | $271.98M | $459.90M | -15.2% |
| Total operating expense | $526.79M | $508.98M | $490.39M | $496.78M | $520.43M | +3.5% |
| Operating income | -$117.34M | -$26.11M | -$72.31M | -$224.80M | -$60.52M | -349.3% |
| Net interest income | -$77.32M | -$79.22M | -$71.66M | -$110.44M | -$104.00M | +2.4% |
| Pre-tax income | -$187.38M | -$79.00M | -$156.75M | -$330.18M | -$156.61M | -137.2% |
| Tax provision | -$309.00K | -$1.53M | $102.00K | $94.00K | $4.18M | +79.8% |
| Net income | -$187.17M | -$77.57M | -$156.95M | -$330.38M | -$160.88M | -141.3% |
| Net income to common | -$187.17M | -$77.57M | -$156.95M | -$330.38M | -$160.88M | -141.3% |
| Basic EPS | -8.40 | -3.48 | -7.04 | -16.85 | -8.20 | -141.4% |
| Diluted EPS | -8.40 | -3.48 | -7.04 | -16.85 | -8.20 | -141.4% |
| EBIT | -$110.06M | $221.00K | -$85.10M | -$219.74M | -$52.61M | -49,902.7% |
| EBITDA | $613.00K | $117.92M | $27.10M | -$104.80M | $63.15M | -99.5% |
| Basic shares | 22.28M | 22.29M | 22.29M | 19.61M | 19.62M | -0.0% |
| Diluted shares | 22.28M | 22.29M | 22.29M | 19.61M | 19.62M | -0.0% |
| Line item | 2026-03-31 | 2025-03-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $100.49M | $5.75M | +1,646.4% |
| Cash & short-term investments | $105.36M | $8.55M | +1,132.3% |
| Accounts receivable | $2.48B | $1.47B | +68.0% |
| Inventory | $1.38B | $1.60B | -13.6% |
| Total current assets | $4.43B | $3.41B | +29.9% |
| Property, plant & equipment | $4.55B | $4.98B | -8.6% |
| Goodwill & intangibles | $247.55M | $234.49M | +5.6% |
| Total assets | $9.42B | $8.81B | +6.9% |
| Total current liabilities | $5.00B | $3.66B | +36.7% |
| Current debt | $3.99B | $2.75B | +45.3% |
| Long-term debt | $500.00M | $2.80B | -82.1% |
| Total debt | $4.49B | $5.55B | -19.0% |
| Total liabilities | $5.51B | $6.46B | -14.7% |
| Retained earnings | $606.90M | $1.41B | -57.0% |
| Shareholder equity | $3.91B | $2.35B | +66.4% |
| Working capital | -$567.95M | -$245.75M | -131.1% |
| Net tangible assets | $3.66B | $2.11B | +73.1% |
| Shares issued | 22.28M | 19.76M | +12.8% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -8.85 | -8.40 | +5.1% |
| Mar 2026 | 1.90 | -3.48 | -283.2% |
| Dec 2025 | -6.30 | -6.10 | +3.2% |
| Sep 2025 | -8.70 | -11.34 | -30.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | -12.50 | 1 | $5.59B | — |
| Next year | 11.00 | 2 | $7.41B | +32.4% |
Analyst targets & ownership
Mean target$670.00
High target$740.00
Low target$600.00
Implied upside11.48%
Analyst count2
ConsensusHOLD
Strong buy / Buy1 / 0
Hold0
Sell / Strong sell0 / 1
Held by insiders73.08%
Held by institutions3.02%
Institutions holding2
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
601.35
-0.06% from price
SMA 20
618.02
-2.62% from price
SMA 50
677.00
-11.10% from price
SMA 100
693.41
-13.33% from price
SMA 200
678.25
-11.26% from price
EMA 12
606.78
-0.95% from price
EMA 26
629.48
-4.52% from price
EMA 50
656.38
-8.44% from price
RSI (14)
36.3
Neutral
MACD (12,26,9)
-22.69
Hist 1.70
ATR (14)
24.17
4.02% of price
Realised vol 30D
26.0%
Annualised
Bollinger upper
661.60
20, 2σ
Bollinger lower
574.45
20, 2σ
50 / 200 cross
Death
677.00 vs 678.25
Trend bias
Below 200
-11.26%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.15
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
26.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-43.2%
Peak to trough
Max drawdown 5Y
-76.8%
Peak to trough
ATR 14
24.17
4.02% of price
Beta (reported)
0.20
5Y monthly, from filing
Headlines
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Insider Monkey · 12m ago
Dow Jones Futures Fall With Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 15m ago
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
AFP · 18m ago
FIA Hails Success of Landmark INDYCAR Freedom 250 Grand Prix as Motorsport Takes Centre Stage in Washington D.C.
Business Wire · 22m ago
The next big oil trade may have nothing to do with oil stocks
TheStreet · 22m ago
First lady Melania Trump says she 'loved' racing as a child
USA TODAY · 23m ago
Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?
Insider Monkey · 23m ago
Crowder College offering training courses in August, September
The Joplin Globe, Mo. · 24m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.